Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lineage Cell Therapeutics (LCTX) Tax Rate: 2014-2023

Historic Tax Rate for Lineage Cell Therapeutics (LCTX) over the last 1 years, with Mar 2023 value amounting to 29.05%.

  • Lineage Cell Therapeutics' Tax Rate was N/A to 29.05% in Q1 2023 from the same period last year, while for Mar 2023 it was 65.32%, marking a year-over-year change of. This contributed to the annual value of 7.74% for FY2023, which is N/A change from last year.
  • As of Q1 2023, Lineage Cell Therapeutics' Tax Rate stood at 29.05%, which was up 153.91% from 11.44% recorded in Q3 2021.
  • Over the past 5 years, Lineage Cell Therapeutics' Tax Rate peaked at 29.05% during Q1 2023, and registered a low of 11.44% during Q3 2021.
  • Moreover, its 2-year median value for Tax Rate was 20.24% (2021), whereas its average is 20.24%.